Loading company details...
Latest Form 4 (Nov 12, 2026): Kerry M. Clem (Chief Commercial Officer): Grant/Award of 200,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | Kerry M. Clem, Chief Commercial Officer | Grant/Award | 200,000 | n/a |
| Nov 12, 2026 | Knuettel Francis II, Chief Financial Officer | Grant/Award | 250,000 | n/a |
| Oct 31, 2026 | Robert Petit, Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated | Grant/Award | 200,000 | n/a |
| Oct 31, 2026 | Avril Suzette Mckean-Dieser | Grant/Award | 300,000 | n/a |
| Oct 31, 2026 | Paul A. Romness, President and CEO | Grant/Award | 900,000 | n/a |
| Oct 31, 2026 | Theodore F. Search | Grant/Award | 300,000 | n/a |
| Oct 31, 2026 | John Ciccio | Grant/Award | 300,000 | n/a |
| Oct 31, 2026 | Olivier Roger Jarry | Grant/Award | 300,000 | n/a |
| Oct 31, 2026 | Craig Eagle | Grant/Award | 300,000 | n/a |
| Oct 31, 2026 | Knuettel Francis II, Chief Financial Officer | Grant/Award | 300,000 | n/a |